Literature DB >> 13523

Detection of serum-blocking factors by inhibition of allorosette formation in rats with long-surviving renal allografts following short-term postoperative ALS treatment.

T S Lie, M Kanda, W I Kim, P Oehr, A Holst, S K Choi, H J Biersack.   

Abstract

Thirty-nine (LEW x BN)F1 kidneys were transplanted to LEW rats. Twenty-four untreated recipients survived for a mean time of 16.1 +/- 1.7 days (group 1). Fifteen recipients received 4 ml of antilymphocytic serum per rat (group 3). In the last group 10 recipients survived for more than 4 months. The spleen cells of these permanently surviving 10 rats were obtained by splenectomy and used in a graft-versus-host assay, and this assay showed that the reactivity of these cells was normal. Following splenectomy the animals were given an (LEW x BN)F1 skin allograft, followed 18 days by a second. After another 18 days (LEW x Buf)F1 "third party" skin allografts were transplanted to the same animals. Animals of group 2 rejected their first grafts with a mean survival time of 12.2 +/- 1.2 days, whereas the second grafts were rejected normally as were the third party grafts. Attempts were made to detect lymphocytotoxic antibodies and haemagglutinins before and after the transplantation of skin grafts and none could be found up to day 53. The sera of group 2 inhibited allorosette formation by 38%. This serum-blocking factor was donor specific. It is probable that the survival of the kidney transplants following antilymphocytic serum treatment was brought about by the development of blocking antibodies.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 13523     DOI: 10.1097/00007890-197701000-00001

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  1 in total

1.  [Active enhancement of canine liver allograft by pretreatment with polyspecific spleen alloantigen (author's transl)].

Authors:  T S Lie; A Holst; M Kanda; P Oehr; G S Rau; H J Biersack; K Rommelsheim; U Grünn
Journal:  Langenbecks Arch Chir       Date:  1977-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.